Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor–mediated kidney fibrosis
Jian-dong Zhang, … , Daian Chen, Steven D. Crowley
Jian-dong Zhang, … , Daian Chen, Steven D. Crowley
Published April 17, 2014
Citation Information: J Clin Invest. 2014;124(5):2198-2203. https://doi.org/10.1172/JCI61368.
View: Text | PDF
Brief Report Nephrology

Type 1 angiotensin receptors on macrophages ameliorate IL-1 receptor–mediated kidney fibrosis

  • Text
  • PDF
Abstract

In a wide array of kidney diseases, type 1 angiotensin (AT1) receptors are present on the immune cells that infiltrate the renal interstitium. Here, we examined the actions of AT1 receptors on macrophages in progressive renal fibrosis and found that macrophage-specific AT1 receptor deficiency exacerbates kidney fibrosis induced by unilateral ureteral obstruction (UUO). Macrophages isolated from obstructed kidneys of mice lacking AT1 receptors solely on macrophages had heightened expression of proinflammatory M1 cytokines, including IL-1. Evaluation of isolated AT1 receptor–deficient macrophages confirmed the propensity of these cells to produce exaggerated levels of M1 cytokines, which led to more severe renal epithelial cell damage via IL-1 receptor activation in coculture compared with WT macrophages. A murine kidney crosstransplantation concomitant with UUO model revealed that augmentation of renal fibrosis instigated by AT1 receptor–deficient macrophages is mediated by IL-1 receptor stimulation in the kidney. This study indicates that a key role of AT1 receptors on macrophages is to protect the kidney from fibrosis by limiting activation of IL-1 receptors in the kidney.

Authors

Jian-dong Zhang, Mehul B. Patel, Robert Griffiths, Paul C. Dolber, Phillip Ruiz, Matthew A. Sparks, Johannes Stegbauer, Huixia Jin, Jose A. Gomez, Anne F. Buckley, William S. Lefler, Daian Chen, Steven D. Crowley

×

Figure 3

Activation of the kidney IL-1R mediates exaggerated renal damage induced by AT1A receptor–deficient macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Activation of the kidney IL-1R mediates exaggerated renal damage induced...
(A) Right panel shows section of a WT kidney transplanted into a LysM-Cre+ mT/mG recipient and subjected to ureteral obstruction (KT-UO). Green fluorescence marks infiltrating LysM+ myeloid cells from recipient. Left panel shows section of an unobstructed native contralateral kidney from the same LysM-Cre+ mT/mG recipient. (B) Right panel shows section of a LysM-Cre+ mT/mG kidney transplanted into a non-Cre mT/mG recipient and subjected to ureteral obstruction. Green fluorescence marks LysM+ macrophages resident in KT-UO kidney. Left panel shows section of an unobstructed native contralateral kidney from the same non-Cre mT/mG recipient. Blue fluorescence is a nuclear DAPI stain. Original magnification, ×20. (C–E) Use of KT-UO model to dissect the contribution of WT vs. AT1 receptor–deficient macrophages to kidney damage mediated through renal IL-1R activation. WT (Macro AT1A WT) or Macro KO (KO) recipients were transplanted with an IL-1R WT or KO kidney subjected to UUO (groups I–IV as in Supplemental Table 2; n = 6–7 per group). (C) Representative polarized images of obstructed kidneys stained with picrosirius red at day 7 KT-UO. Original magnification, ×20. Quantitation is shown on the right. Excessive fibrosis due to AT1 receptor deficiency on macrophages in Macro KO recipient is abrogated in IL-1R–deficient donor kidneys. mRNA expression of (D) Col I and (E) NGAL in obstructed kidneys 7 days after KT-UO.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts